Evidence map›Paper›PMID 41944989›Full record

ArticleCEN case reports2026

CART for ascites accumulation and dialysis difficulty after hepatic cyst fenestration and bilateral nephrectomy in ADPKD: a case report.

Saori Sawada, Sho Sugahara, Anna Sumii, Tomonori Sakae, Aki Yamada, Yoshimi Imamura-Uehara, Nahomi Ishimoto, Shogo Kuwagata, Kosuke Yamahara, Mako Yasuda-Yamahara and 3 more

Abstract readCase Reports
In one paragraph

Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Saori SawadaDivision of Diabetes, Endocrinology and Nephrology, Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.
Sho SugaharaDivision of Diabetes, Endocrinology and Nephrology, Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan. ssho1984@belle.shiga-med.ac.jp.ORCID 0000-0003-0578-8063
Anna SumiiDivision of Diabetes, Endocrinology and Nephrology, Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.
Tomonori SakaeDivision of Diabetes, Endocrinology and Nephrology, Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.
Aki YamadaDivision of Diabetes, Endocrinology and Nephrology, Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.
Yoshimi Imamura-UeharaDivision of Diabetes, Endocrinology and Nephrology, Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.
Nahomi IshimotoDivision of Diabetes, Endocrinology and Nephrology, Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.
Shogo KuwagataDivision of Diabetes, Endocrinology and Nephrology, Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.
Kosuke YamaharaDivision of Diabetes, Endocrinology and Nephrology, Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.
Mako Yasuda-YamaharaDivision of Diabetes, Endocrinology and Nephrology, Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.
Yuki Tanaka-SasakiDivision of Diabetes, Endocrinology and Nephrology, Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.
Masami Chin-KanasakiDivision of Diabetes, Endocrinology and Nephrology, Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan. msm@belle.shiga-med.ac.jp.
Shinji KumeDivision of Diabetes, Endocrinology and Nephrology, Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatomegaly with hepatic cysts constitutes a common extrarenal manifestation of autosomal dominant polycystic kidney disease (ADPKD), often resulting in mass effects and occasionally necessitating cyst fenestration to alleviate abdominal distension. Nonetheless, persistent cyst fluid leakage as a postoperative complication frequently leads to refractory ascites, for which treatment options are limited. In this report, we present a 62-year-old female patient with ADPKD undergoing maintenance hemodialysis. She received bilateral nephrectomy and hepatic cyst fenestration to mitigate abdominal distension. Postoperatively, she developed ascites accumulation and recurrent intradialytic hypotension, impairing effective ultrafiltration. The ascites proved unresponsive to conservative management, and analysis indicated hepatic cyst fluid leakage, with elevated CA19-9 levels in the ascitic fluid. Repeated ultrafiltration and abdominal paracentesis failed to produce sustained benefits. Subsequently, she underwent two sessions of cell-free and concentrated ascites reinfusion therapy (CART), which successfully reduced her ascites. Over the subsequent four months, her serum albumin levels increased, intradialytic hypotension resolved, and the ascites subsided without recurrence, thus permitting the repair of an inguinal hernia identified at referral. This case exemplifies that CART constitutes an effective therapeutic modality for managing ascites accumulation resulting from hepatic cyst leakage following fenestration in patients with ADPKD.

Indexed as

AscitesCystsLiver DiseasesNephrectomyPolycystic Kidney, Autosomal DominantRenal DialysisAscitic FluidFemaleHumansMiddle AgedPostoperative ComplicationsTreatment OutcomeAscites accumulationAutosomal dominant polycystic kidney diseaseCell-free and concentrated ascites reinfusion therapyHepatic cyst fenestration

Identifiers

PMID41944989
PMCPMC13057055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.